Analyst Reco. CorMedix Inc.

Equities

CRMD

US21900C3088

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-01 pm EDT			5-day change	1st Jan Change
5.52 ^USD	+5.04%		+3.56%	+46.81%

Apr. 15	CorMedix's DefenCath Now Commercially Available For US Inpatient Use	MT
Apr. 15	CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath®? (Taurolidine and Heparin)	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

RBC Trims Price Target on CorMedix to $9 From $10, Keeps Outperform Rating, Speculative Risk Qualifier	Mar. 13	MT
RBC Boosts Price Target on CorMedix to $10 From $6 on 'Heightening Prospects of DefenCath Reaching Market,' Keeps Outperform, Speculative Risk	Nov. 15	MT
RBC Initiates CorMedix at Outperform, Speculative Risk With $6 Price Target, Sees DefenCath 'More Likely Than Not to Be Approved'	23-08-10	MT
JMP Securities Adjusts Price Target on CorMedix to $19 From $16, Keeps Market Outperform Rating	23-05-19	MT
JMP Securities Adjusts CorMedix's Price Target to $16 From $14, Keeps Market Perform Rating	23-03-01	MT
Truist Securities Lowers CorMedix's Price Target to $16 From $27, Maintains Buy Rating	22-08-12	MT
JMP Securities Adjusts CorMedix Price Target to $14 From $19, Maintains Market Outperform Rating	22-08-09	MT
Needham Adjusts CorMedix's Price Target to $12 from $20, Keeps Buy Rating	22-08-09	MT
CORMEDIX : Needham & Co Adjusts CorMedix PT to $29 From $31, Maintains Buy Rating	21-05-14	MT
CORMEDIX : B. Riley Lowers CorMedix' Price Target to $13.50 from $25 After FDA Rejects DefenCath Due to Manufacturing Issues, Keeps Buy Rating	21-03-02	MT
CORMEDIX : Needham Starts CorMedix at Buy With $31 Price Target	21-02-17	MT
CORMEDIX : B. Riley Adjusts CorMedix' Price Target to $25 From $11, Keeps Buy Rating	21-02-09	MT
CORMEDIX : Truist Securities Adjusts CorMedix PT to $35 From $20, Maintains Buy Rating	21-02-02	MT
CORMEDIX : Truist Securities Adjusts CorMedix' Price Target to $35 from $20, Keeps Buy Rating	21-02-02	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Discover our Free Content to Help You Better Understand the Stock Market.

100% Free Registration

fermer